Brendan Luu - Net Worth and Insider Trading
Brendan Luu Net Worth
The estimated net worth of Brendan Luu is at least $413,647 dollars as of 2024-11-05. Brendan Luu is the Sr. VP, Business Dev. of Enanta Pharmaceuticals Inc and owns about 36,736 shares of Enanta Pharmaceuticals Inc (ENTA) stock worth over $413,647. Details can be seen in Brendan Luu's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brendan Luu has not made any transactions after 2023-12-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Brendan Luu
Brendan Luu Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Brendan Luu owns 1 companies in total, including Enanta Pharmaceuticals Inc (ENTA) .
Click here to see the complete history of Brendan Luu’s form 4 insider trades.
Insider Ownership Summary of Brendan Luu
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ENTA | Enanta Pharmaceuticals Inc | 2023-12-05 | Sr. VP & Business Dev. |
Brendan Luu Latest Holdings Summary
Brendan Luu currently owns a total of 1 stock. Brendan Luu owns 36,736 shares of Enanta Pharmaceuticals Inc (ENTA) as of December 5, 2023, with a value of $413,647.
Latest Holdings of Brendan Luu
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ENTA | Enanta Pharmaceuticals Inc | 2023-12-05 | 36,736 | 11.26 | 413,647 |
Holding Weightings of Brendan Luu
Brendan Luu Form 4 Trading Tracker
According to the SEC Form 4 filings, Brendan Luu has made a total of 1 transactions in Enanta Pharmaceuticals Inc (ENTA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Enanta Pharmaceuticals Inc is the sale of 2,125 shares on December 5, 2023, which brought Brendan Luu around $20,464.
Insider Trading History of Brendan Luu
- 1
Brendan Luu Trading Performance
Brendan Luu Ownership Network
Ownership Network List of Brendan Luu
Ownership Network Relation of Brendan Luu
Brendan Luu Owned Company Details
What does Enanta Pharmaceuticals Inc do?
Who are the key executives at Enanta Pharmaceuticals Inc?
Brendan Luu is the Sr. VP & Business Dev. of Enanta Pharmaceuticals Inc. Other key executives at Enanta Pharmaceuticals Inc include Chief Medical Officer Scott T. Rottinghaus , Sr. VP & New Product Dev. Tara Lynn Kieffer , and Chief Scientific Officer Yat Sun Or .
Enanta Pharmaceuticals Inc (ENTA) Insider Trades Summary
Over the past 18 months, Brendan Luu made 1 insider transaction in Enanta Pharmaceuticals Inc (ENTA) with a net sale of 2,125. Other recent insider transactions involving Enanta Pharmaceuticals Inc (ENTA) include a net sale of 12,479 shares made by Scott T. Rottinghaus , a net sale of 9,391 shares made by Tara Lynn Kieffer , and a net sale of 15,295 shares made by Terry Vance .
In summary, during the past 3 months, insiders sold 0 shares of Enanta Pharmaceuticals Inc (ENTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 53,756 shares of Enanta Pharmaceuticals Inc (ENTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 53,756 shares.
Enanta Pharmaceuticals Inc (ENTA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Enanta Pharmaceuticals Inc Insider Transactions
Brendan Luu Mailing Address
Above is the net worth, insider trading, and ownership report for Brendan Luu. You might contact Brendan Luu via mailing address: C/o Enanta Pharmaceuticals, Inc., 500 Arsenal Street, Watertown Ma 02472.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
